| Literature DB >> 31652800 |
Zhaoming Liu1, Zhen Fan2, Zhanghua Sun3, Hongxin Liu4, Weimin Zhang5.
Abstract
Dechdigliotoxins A-C (1-3), which represented the first examples of gliotoxin dimers with an unprecedented exocyclic disulfide linkage, were obtained from a deep-sea derived fungus Dichotomomyces cejpii FS110. The structures of these compounds were elucidated on the basis of spectroscopic analysis and the absolute configurations were unambiguously determined through quantum chemical calculations, as well as DP4+ probability simulations. The proposed biosynthetic pathway suggested 1-3 were generated from unusual L-Phe and D-Ser. All the isolates were evaluated for their cytotoxicity against four tumor cell lines.Entities:
Keywords: cytotoxicity; dechdigliotoxins; deep-sea derived fungus; dimer; disulfide-bridged; quantum chemical calculations
Mesh:
Substances:
Year: 2019 PMID: 31652800 PMCID: PMC6891313 DOI: 10.3390/md17110596
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1The structures of 1–7.
Figure 2Key HMBC (red arrows) and 1H, 1H-COSY (blue bold bond) correlation of 1–3.
Figure 3Key NOESY correlations of 1.
Figure 4Correlation plots of experimental and calculated 13C NMR, as well as DP4+ simulation of 1a and 1b.
Figure 5Experimental and calculated ECD spectra of 1a/ent-1a and 1b/ent-1b.
Figure 6Key NOESY correlations of 2 and 3 recorded in DMSO.
Figure 7Experimental ECD spectra of 1 and 2.
In vitro cytotoxicity against tested cancer cell lines of 1–7.
| Compounds | IC50 (μM) | |||
|---|---|---|---|---|
| SF-268 | MCF-7 | NCI-H460 | HepG-2 | |
| 1–5 | >100 | >100 | >100 | >100 |
| 6 | 0.24 ± 0.10 | 0.08 ± 0.00 | 0.24 ± 0.01 | 0.21 ± 0.01 |
| 7 | 0.25 ± 0.03 | 0.22 ± 0.04 | 0.32 ± 0.02 | 0.49 ± 0.07 |
| Cisplatin | 2.37 ± 0.35 | 3.09 ± 0.27 | 2.43 ± 0.15 | 1.39 ± 0.18 |
Figure 8Correlation plots of experimental and calculated 13C NMR, as well as DP4+ simulation of 3a and 3b.
Figure 9Experimental and calculated ECD spectra of 3a/ent-3a and 3b/ent-3b.
Scheme 1Possible biosynthesis pathway of 1–3.